<div id="readability-page-1"><p>Bath &amp; Body Works, Inc. (NYSE:BBWI - Get Free Report)'s share price shot up 3.3% on Monday . The company traded as high as $20.45 and last traded at $20.4450. 4,271,007 shares changed hands during trading, a decline of 29% from the average session volume of 6,043,855 shares. The stock had previously closed at $19.79.</p><div><p><span></span><span>Get <strong>Bath &amp; Body Works</strong> alerts:</span></p></div><h2>Analyst Ratings Changes</h2><ul><li>Bath &amp; Body Works Hits Multi-Year Lows: Bargain or Trap?</li></ul><p>A number of analysts have issued reports on the company. Barclays decreased their price target on Bath &amp; Body Works from $28.00 to $18.00 and set an &#34;equal weight&#34; rating on the stock in a research note on Friday, November 21st. Telsey Advisory Group downgraded shares of Bath &amp; Body Works from an &#34;outperform&#34; rating to a &#34;market perform&#34; rating and cut their target price for the company from $38.00 to $17.00 in a research note on Friday, November 21st. Zacks Research cut shares of Bath &amp; Body Works from a &#34;hold&#34; rating to a &#34;strong sell&#34; rating in a research report on Monday, November 24th. UBS Group lowered their price target on Bath &amp; Body Works from $32.00 to $17.00 and set a &#34;neutral&#34; rating for the company in a report on Friday, November 21st. Finally, New Street Research  set a $26.00 target price on Bath &amp; Body Works in a report on Monday, November 24th. Five investment analysts have rated the stock with a Buy rating, thirteen have issued  a Hold rating and one  has given a Sell rating to the stock. Based on data from MarketBeat.com, Bath &amp; Body Works presently has an average rating of &#34;Hold&#34; and an average target price of $23.61.</p><p><b>Get Our Latest Research Report on BBWI</b></p><h2>Bath &amp; Body Works Stock Performance</h2><ul><li>How Bath &amp; Body Works Is a Perfect Example of a Value Stock </li></ul><p>The company's fifty day moving average price is $21.06 and its 200 day moving average price is $26.15. The firm has a market capitalization of $4.20 billion, a price-to-earnings ratio of 6.31, a price-to-earnings-growth ratio of 0.73 and a beta of 1.51. </p><p>Bath &amp; Body Works (NYSE:BBWI - Get Free Report) last released its quarterly earnings data on Thursday, November 20th. The company reported $0.35 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.40 by ($0.05). The company had revenue of $1.59 billion for the quarter, compared to analyst estimates of $1.64 billion. Bath &amp; Body Works had a net margin of 9.50% and a negative return on equity of 47.35%. The company's revenue for the quarter was down 1.0% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.49 EPS. Bath &amp; Body Works has set its FY 2025 guidance at 2.870- EPS and its Q4 2025 guidance at 1.700- EPS.  As a group, sell-side analysts expect that  Bath &amp; Body Works, Inc. will post 3.3 earnings per share for the current year. </p><h2>Bath &amp; Body Works Announces Dividend</h2><ul><li>Retail’s Comeback: 3 High-ROIC Stocks That Could Outshine AI</li></ul><p>The company also recently announced a quarterly dividend, which was paid on Friday, December 5th. Investors of record on Friday, November 21st were issued a dividend of $0.20 per share. The ex-dividend date of this dividend was Friday, November 21st. This represents a $0.80 annualized dividend and a yield of 3.9%. Bath &amp; Body Works's payout ratio is presently 24.62%. </p><h2>Insider Transactions at Bath &amp; Body Works</h2><p>In other Bath &amp; Body Works news, Director Lucy Brady purchased 3,470 shares of the company's stock in a transaction on Friday, November 21st. The shares were purchased at an average cost of $14.40 per share, for a total transaction of $49,968.00. Following the completion of the transaction, the director owned 17,482 shares in the company, valued at $251,740.80. The trade was a 24.76% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities &amp; Exchange Commission, which is available through the SEC website. Also, Director Steven E. Voskuil acquired 20,000 shares of Bath &amp; Body Works stock in a transaction dated Friday, November 21st. The shares were acquired at an average price of $15.04 per share, with a total value of $300,800.00. Following the transaction, the director owned 33,925 shares in the company, valued at approximately $510,232. This represents a 143.63% increase in their position. The disclosure for this purchase is available in the SEC filing. Over the last ninety days, insiders acquired 33,513 shares of company stock worth $500,442. Corporate insiders own  0.27% of the company's stock. </p><h2>Institutional Investors Weigh In On Bath &amp; Body Works</h2><p>Several hedge funds have recently bought and sold shares of BBWI. Summit Investment Advisors Inc. acquired a new stake in shares of  Bath &amp; Body Works during the 1st quarter valued at about $1,292,000.  Intech Investment Management LLC raised its position in  Bath &amp; Body Works by 53.5% in the second quarter. Intech Investment Management LLC now owns 58,460 shares of the company's stock worth $1,751,000 after purchasing an additional 20,381 shares in the last quarter.  JPMorgan Chase &amp; Co. lifted its stake in  Bath &amp; Body Works by 11.5% during the second quarter. JPMorgan Chase &amp; Co. now owns 7,080,106 shares of the company's stock worth $212,120,000 after purchasing an additional 733,000 shares during the period.  Mitsubishi UFJ Trust &amp; Banking Corp boosted its holdings in  Bath &amp; Body Works by 126.3% during the second quarter. Mitsubishi UFJ Trust &amp; Banking Corp now owns 271,727 shares of the company's stock valued at $8,141,000 after purchasing an additional 151,668 shares in the last quarter.  Finally, Kingsview Wealth Management LLC bought a new stake in shares of  Bath &amp; Body Works in the 2nd quarter valued at approximately $2,906,000. 95.14% of the stock is owned by hedge funds and other institutional investors. </p><h2>Bath &amp; Body Works Company Profile</h2> (Get Free Report)<p>Bath &amp; Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath &amp; Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath &amp; Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.  </p><p>Founded in 1990 as part of Limited Brands (now L Brands), Bath &amp; Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.</p><h2>Read More</h2><ul><li>Five stocks we like better than Bath &amp; Body Works</li><li>Do not delete, read immediately</li><li>How the Rich Retire</li><li>INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off</li><li>How Long Will $1M Last in Retirement?</li><li>[No Brainer Gold Play]: “Show me a better investment.”</li></ul><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Bath &amp; Body Works Right Now?</h2><p>Before you consider Bath &amp; Body Works, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bath &amp; Body Works wasn't on the list.</p><p>While Bath &amp; Body Works currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

BBWI

<p>Bath & Body Works (NYSE:BBWI) shares rose 3.3% to $20.45, with 4.27 million shares traded. Analysts have downgraded the stock, with Barclays setting a target of $18 and Telsey Advisory Group lowering it to $17. The company reported Q3 earnings of $0.35 EPS, missing estimates, and revenue of $1.59 billion. A quarterly dividend of $0.20 was recently paid, yielding 3.9%. Insider purchases were noted, with significant acquisitions by directors. The average analyst rating is "Hold" with a target price of $23.61.</p>

Bath & Body Works (NYSE:BBWI) Stock Price Up 3.3% - What's Next?